CME Group Inc. (CME)
CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume
CME posts Q2 beats on earnings and revenue as record trading volume and rising fees lift results amid market volatility.
Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings
The headline numbers for CME (CME) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) Surpasses Q2 Earnings and Revenue Estimates
CME Group (CME) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.91 per share. This compares to earnings of $2.56 per share a year ago.
Is a Beat in the Cards for CME Group This Earnings Season?
CME's second-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
Stay Ahead of the Game With CME (CME) Q2 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for CME (CME), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win
CME Group gets rated buy again, reaffirming my last rating. The firm is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key peers, and cashflow growth. Two key business segments of operating exchanges, as well as providing market data to subscribers, have seen demand growth.
If I Could Only Buy 2 Dividend Stocks Right Now - These Would Be It
Inflation isn't going away. In fact, it may soon be fueled deliberately. That makes owning hard assets and top-tier dividend stocks essential. I've identified two stocks that thrive in this new reality, each built to handle inflation, deliver income, and offer long-term upside. These aren't random picks. They're special. If I could buy only two dividend stocks for what's coming, I'd seriously consider these.
Capitalize on Volatility: 3 Finance Stocks Thriving in 2025
Markets may hate uncertainty, but in 2025, they seem to love volatility. Despite cloudy and, at times, contradictory economic indicators, the NASDAQ and S&P 500 indices reached all-time highs to close out the second quarter.
3 Bitcoin-Centric Stocks in Focus Amid Ongoing Geopolitical Tensions
As Bitcoin holds above $100K despite global tensions, CME, Visa and PayPal emerge as crypto plays with 2025 upside.
2 Dividend Stocks I'd Marry If I Could
Markets are chaotic, headlines rule, and short-term forecasts are pointless. That's why I focus on long-term dividend investing with wide-moat stocks. In this environment, I'm doubling down on two of my favorite dividend stocks, which are built for uncertainty, strong cash flow, and dependable dividends. With long-term conviction, I keep using market weakness to add to these holdings. I'm sticking to this playbook for compounding success.
